Аннотации:
The administration of Aescusan into the complex treatment program of patients with hypothyroidism was found to increase total plasma fibrinolysis almost to the control level, normalize the intensity of non-enzymatic fibrinolysis, considerably elevate the enzymatic lysis of fibrine and more effectively, as compared with standard treatment program, restore normal structure of plasma fibrinolysis.